Original BioMedicals Co., Ltd. (TPEX:6483)
Taiwan · Delayed Price · Currency is TWD 13.70
+0.05 (0.37%)
Aug 19, 2026, 10:51 AM CST
Original BioMedicals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 60.77 | 133.85 | 151.45 | 228.68 | 13.98 | 8.46 |
Short-Term Investments | 10 | 9.99 | 89.74 | 99.8 | 34.93 | 74.85 |
Cash & Short-Term Investments | 70.77 | 143.84 | 241.19 | 328.48 | 48.91 | 83.31 |
Cash Growth | -64.21% | -40.36% | -26.57% | 571.60% | -41.29% | 928.77% |
Other Receivables | 0.32 | 13.99 | 13.51 | 11.55 | 9.99 | 9.59 |
Receivables | 0.32 | 13.99 | 13.51 | 11.55 | 9.99 | 9.59 |
Other Current Assets | 44.93 | 6.2 | 1.61 | 1.37 | 0.89 | 1.55 |
Total Current Assets | 116.02 | 164.03 | 256.31 | 341.4 | 59.79 | 94.46 |
Property, Plant & Equipment | 16.51 | 18.75 | 21.9 | 28.08 | 36.19 | 41.03 |
Other Long-Term Assets | 1.16 | 1.16 | 1.16 | 1.16 | 2.05 | 1.88 |
Total Assets | 134.17 | 183.94 | 279.37 | 370.63 | 98.04 | 137.37 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accrued Expenses | - | 10.56 | 8.56 | 7.48 | 4.29 | 3.93 |
Current Portion of Leases | 4.7 | 4.17 | 4.52 | 4.26 | 3.62 | 3.14 |
Other Current Liabilities | 11.84 | 2.12 | 1.35 | 18.12 | 2.46 | 1.44 |
Total Current Liabilities | 16.53 | 16.84 | 14.43 | 29.86 | 10.36 | 8.52 |
Long-Term Leases | 4.46 | 7.03 | 7.47 | 11.98 | 16.27 | 17.52 |
Other Long-Term Liabilities | 2.23 | 2.23 | 2.23 | 2.23 | 2.23 | 2.23 |
Total Liabilities | 23.22 | 26.1 | 24.12 | 44.07 | 28.86 | 28.26 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 668.08 | 665.89 | 659.92 | 655.5 | 470.5 | 470.5 |
Additional Paid-In Capital | - | 1.06 | 384.17 | 384.9 | 252.85 | 252.51 |
Retained Earnings | -557.59 | -509.12 | -788.83 | -713.84 | -654.18 | -613.9 |
Comprehensive Income & Other | 0.46 | - | - | - | - | - |
Shareholders' Equity | 110.95 | 157.84 | 255.25 | 326.57 | 69.17 | 109.11 |
Total Liabilities & Equity | 134.17 | 183.94 | 279.37 | 370.63 | 98.04 | 137.37 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 9.16 | 11.19 | 11.98 | 16.24 | 19.89 | 20.66 |
Net Cash (Debt) | 61.61 | 132.65 | 229.21 | 312.24 | 29.02 | 62.65 |
Net Cash Growth | -67.22% | -42.13% | -26.59% | 976.08% | -53.69% | - |
Net Cash Per Share | 0.92 | 2.00 | 3.47 | 6.33 | 0.62 | 1.51 |
Filing Date Shares Outstanding | 67.13 | 66.59 | 65.99 | 65.55 | 47.05 | 47.05 |
Total Common Shares Outstanding | 67.13 | 66.59 | 65.99 | 65.55 | 47.05 | 47.05 |
Working Capital | 99.49 | 147.18 | 241.88 | 311.54 | 49.43 | 85.94 |
Book Value Per Share | 1.65 | 2.37 | 3.87 | 4.98 | 1.47 | 2.32 |
Tangible Book Value | 110.48 | 157.84 | 255.25 | 326.57 | 69.17 | 109.11 |
Tangible Book Value Per Share | 1.65 | 2.37 | 3.87 | 4.98 | 1.47 | 2.32 |
Machinery | - | 4.67 | 44.92 | 47.15 | 46.96 | 46.84 |
Leasehold Improvements | - | 36.85 | 36.85 | 36.85 | 36.73 | 36.38 |